 
                                    
                            01
 
                                    
                            01
 
                                    
                            02
 
                                    
                            03
Can circular dichroism offer greater sensitivity when analyzing changes to therapeutic antibodies?
 
                                    
                            04
FDA: Circular dichroism for the characterization of high order structure of biotherapeutics